PARADISI, FRANCO
 Distribuzione geografica
Continente #
NA - Nord America 8.653
EU - Europa 8.237
AS - Asia 1.107
AF - Africa 46
SA - Sud America 28
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 18.076
Nazione #
US - Stati Uniti d'America 8.623
PL - Polonia 3.288
RU - Federazione Russa 1.613
UA - Ucraina 743
IE - Irlanda 596
SE - Svezia 542
IT - Italia 508
DE - Germania 490
SG - Singapore 395
HK - Hong Kong 315
FI - Finlandia 232
GB - Regno Unito 116
IN - India 106
CN - Cina 105
FR - Francia 54
VN - Vietnam 54
TR - Turchia 48
SC - Seychelles 39
CA - Canada 28
KR - Corea 27
JO - Giordania 24
BG - Bulgaria 16
TH - Thailandia 15
AR - Argentina 9
BO - Bolivia 9
NL - Olanda 8
IR - Iran 6
PT - Portogallo 6
BR - Brasile 5
AL - Albania 4
CH - Svizzera 4
CZ - Repubblica Ceca 4
AT - Austria 3
CI - Costa d'Avorio 3
CO - Colombia 3
AU - Australia 2
BE - Belgio 2
DK - Danimarca 2
IL - Israele 2
IQ - Iraq 2
JP - Giappone 2
NZ - Nuova Zelanda 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BD - Bangladesh 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
EU - Europa 1
GH - Ghana 1
GR - Grecia 1
HU - Ungheria 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MU - Mauritius 1
MZ - Mozambico 1
NG - Nigeria 1
PE - Perù 1
PK - Pakistan 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 18.076
Città #
Warsaw 3.286
Santa Clara 2.255
Jacksonville 1.137
Chandler 701
Dublin 596
Fairfield 539
Singapore 303
Wilmington 299
Cambridge 275
Woodbridge 242
Boardman 219
Princeton 212
Ashburn 211
Houston 183
Boston 171
Seattle 161
Hong Kong 138
Mumbai 103
Ann Arbor 89
Medford 86
Buffalo 80
Lawrence 77
Altamura 76
Beijing 65
Los Angeles 61
New York 54
San Diego 50
Dong Ket 49
Auburn Hills 46
Frankfurt Am Main 44
Izmir 41
Norwalk 41
Milan 40
Moscow 34
Verona 33
Hillsboro 32
Andover 26
Florence 26
Toronto 21
Helsinki 19
Shanghai 17
Dearborn 16
Kent 15
Sofia 15
Bremen 14
Munich 14
Yubileyny 14
Bangkok 13
Phoenix 12
Rome 12
Seongnam 12
Redwood City 11
San Mateo 11
London 10
Seoul 10
Naples 9
Laurel 8
Catania 7
Santa Cruz 7
Buenos Aires 5
Delray Beach 4
Falls Church 4
Ottawa 4
Padova 4
Portland 4
Abidjan 3
Augusta 3
Decatur 3
Fucecchio 3
Hanover 3
Kilburn 3
Leawood 3
Montréal 3
Prato 3
Westerville 3
Aci Catena 2
Acton 2
Arnsberg 2
Arten 2
Auckland 2
Brescia 2
Brussels 2
Cantagallo 2
Capaccio 2
Chon Buri 2
Foresto 2
Forlì 2
Frattamaggiore 2
Genoa 2
Lisbon 2
Livorno 2
Mainz 2
Milazzo 2
Modena 2
Mountain View 2
Munro 2
Nuremberg 2
Perugia 2
Piansano 2
Port of Spain 2
Totale 12.453
Nome #
Antistaphylococcal (MSSA, MRSA, MSSE, MRSE) antibiotics 312
Skeletal tuberculosis and other granulomatous infections 255
Urinary tract infections in the city of Florence: epidemiological considerations over a twenty-year period 251
Is Streptococcus pneumoniae a nosocomially acquired pathogen? 248
Antibiotic resistance in community-acquired pulmonary pathogens 245
Which prophylactic regimen for which surgical procedure? 240
Invasive Streptococcus pyogenes infection in a surgeon after an occupational exposure 239
Streptococcus pneumoniae as an agent of nosocomial infection: treatment in the era of penicillin-resistant strains 239
Effect of antibiotic pretreatment on resistance 236
Once-daily dosing regimen for aminoglycoside plus betalactam combination therapy of serious lower respiratory tract infections 234
Infections in multiple myeloma 233
Ciprofloxacin resistance in clinical isolates of Pseudomonas aeruginosa from Italian patients 227
Antimicrobial resistance in an intensive care unit before adopting an antibiotic rotation programme for empiric therapy of ventilator-associated pneumonia 225
Clinical and microbiologic efficacy and safety profile of linezolid, a new oxazolidinone antibiotic 223
Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia 220
La terapia delle infezioni fungine invasive: dubbi e certezze 207
Toscana virus, a “Mediterranean” agent of aseptic meningitis: analysis of 42 consecutive cases 205
Ruolo del linezolid nella terapia delle infezioni causate da cocchi gram-positivi multiresistenti 205
Nuove prospettive terapeutiche nel trattamento delle infezioni in comunità 204
Penetrazione degli antibiotici in distretti speciali 202
Treatment of otitis media 197
Pathogenetic mechanisms responsible for the production of secondary immunodeficiency 196
Atassia cerebellare acuta in corso di mononucleosi infettiva 195
Terapia delle infezioni intra-addominali complicate: qualcosa è cambiato nel nostro orizzonte terapeutico? 195
Nuove prospettive terapeutiche: fra presente e futuro 195
Terapia antibiotica delle polmoniti nosocomiali 192
Antibiotic resistance in the absence of antimicrobial use: mechanisms and implications. 155
Epidemiology of pneumococcal resistance in Florence: much more erythromycin-nonsusceptible (ENSP) than penicillin-nonsusceptible (PNSP) strains 143
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study 127
Molecular alterations of VanA element in vancomycin-resistant enterococci isolated during a survey of colonized patients in an Italian intensive care unit. 124
Post-traumatic infection of the lower limb caused by rare Enterobacteriaceae and Mucorales in a young healthy male 124
Incidence of penicillin- (PNSP) and erythromycin- (ENSP) nonsusceptible pneumococci in Florence, Italy, 1992-1999 121
Evaluation of a rapid immunochromatographic test for serologic diagnosis of tuberculosis in Italy 119
High prevalence of acquired antimicrobial resistance unrelated to heavy antimicrobial consumption 119
A neuroepidemiological survey in rural Bolivia: background and methods. 118
Serological survey of toxoplasmosis in the Santa Cruz region of Bolivia. 116
Resistenza a ciprofloxacin di stafilococchi coagulasi-negativi meticillino-resistenti isolati nell'area fiorentina 115
Distribution and antibiotic resistance of isolates from lower respiratory tract and blood cultures from patients in three Italian intensive care units: a 2-year comparison. 115
Severe head and neck infections in the critical care unit 114
Is Streptococcus pneumoniae a nosocomially-acquired pathogen? 112
Absence of HIV infection in low- and high-risk groups in the Santa Cruz region, Bolivia. 109
Lumbar pain in a married couple who likes cheese: brucella strikes again! 108
Meropenem versus imipenem/cilastatin in the hospital treatment of community-acquired pneumonia 108
High-level aminoglycoside resistance among enterococci isolated from blood cultures. 107
The influence of ofloxacin versus trimethoprim-sulfamethoxazole on the aerobic flora in granulocytopenic subjects. 107
In vitro activity of MDL 62,879 against Gram-positive bacteria and bacteroides species 104
Considerazioni farmacoeconomiche sulla terapia antibiotica delle infezioni osteo-articolari 104
Effect of a new fluorinated quinolone (ofloxacin) on the chemiluminescence of phagocytosing human neutrophils. 103
Attività comparativa in vitro di meropenem, nuova molecola carbapenemica, nei confronti di batteri gram-positivi e gram-negativi 103
Secondary immunodeficiency 100
Seroprevalence of varicella zoster and rubella antibodies among rural populations of the Chaco region, south-eastern Bolivia. 100
Epilepsy, cysticercosis, and toxocariasis: a population-based case-control study in rural Bolivia. 99
Interactions between antibiotics and immune system 98
Cefepime 98
Population movements and cholera spread in Cordillera Province, Santa Cruz Department, Bolivia. 98
Parasitological observations on three Bolivian localities including rural communities, cities and institutions. 98
High prevalence of acquired antimicrobial resistance unrelated to heavy antimicrobial consumption 97
Attività comparativa in vitro di MDL 62873 nei confronti di microrganismi gram-positivi 97
Prevalence of epilepsy in rural Bolivia: a door-to-door survey. 97
Urosepsis in the critical care unit. 97
Prevalence of leptospiral infections in humans in Cordillera Province, Bolivia. 96
Prevalence of antibodies against hepatitis A and E viruses among rural populations of the Chaco region, south-eastern Bolivia. 95
Antimicrobial agent susceptibility patterns of staphylococci isolated in urban and rural areas of Bolivia 94
Treatment of multidrug-resistant tuberculosis 93
Patterns of antimicrobial use and antimicrobial resistance among healthy children in Bolivia. 93
Le resistenze batteriche mediate da beta-lattamasi a spettro esteso: conseguenze terapeutiche 93
Different broth dilution procedures generate different apparent MICs for ramoplanin 93
Intestinal parasites in the Camiri, Gutierrez and Boyuibe areas, Santa Cruz Department, Bolivia. 92
Alternative antibiotics for methicillin-resistant (MR) staphylococcal skin lesions in at-risk patients: preliminary results of a surveillance programme in Florence, Italy 90
Acquired immunodeficiency 88
Antimicrobial resistance (AR) among respiratory pathogens (RP): a unique epidemiology in Italy 86
Proposal of an improved score method for the diagnosis of pulmonary tuberculosis in childhood in developing countries. 86
Approccio terapeutico alle infezioni nosocomiali 84
Seroepidemiological study of HIV antibody prevalence in the Santa Cruz region, Bolivia. 83
An Italian study on the ciprofloxacin activity against clinical isolates of Pseudomonas aeruginosa 82
Antibiotic resistance of Enterobacteriaceae isolated from the urinary tract 82
Antibodies against Trichinella spiralis in the rural population of the Province of Cordillera, Bolivia] 82
Antibiotic susceptibility of urinary pathogens isolated from hospital practice specimens in the Florence area 82
Terapia delle infezioni batteriche delle vie respiratorie inferiori nell'anziano 81
The link between use of antibiotics and acquisition of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and ciprofloxacin-resistant Pseudomonas aeruginosa (CR-PA) in a cohort of 864 patients 81
Attività in vitro di MDL 62,879 nei confronti di isolati clinici di E.faecalis con e senza resistenza ad altri livelli di aminoglucosidi 81
Multicenter randomised trial comparing meropenem and imipenem cilastatin in the hospital treatment of community acquired pneumonia 80
Comparative in-vitro activity of MDL 62873 against aerobic and anaerobic gram-positive bacteria 79
Pneumococco penicillino- ed eritromicino-insensibile nell’area fiorentina: una realtà epidemiologica in mutamento? 79
Antibiotic therapy of bacterial meningitis 77
Su due casi di mononucleosi infettiva a decorso atipico 77
Seroepidemiological study of HIV antibody prevalence in the Santa Cruz region (Bolivia) 76
Mixed infection of the lower limb caused by rare bacterial and fungal pathogens in a patient with multiple traumatic injuries 76
The role of atypical pathogens in the etiology of community-acquired pneumonia (CAP) in the Florence area 76
Enterococchi e resistenza ad alti livelli di aminoglucosidi: indagine su isolati da emocolture nell'area fiorentina nel periodo 1990-94 76
Frequenza d'isolamento e sensibilità agli antibiotici di microrganismi isolati da urinocolture nel secondo semestre 1990 75
La terapia delle faringo-tonsilliti oggi: quali scelte terapeutiche? 75
Le infezioni nosocomiali delle vie urinarie nell'area fiorentina 75
Lo stafilococco meticillino-resistente: una realtà importante nell’attuale panorama della patologia infettiva 75
L'impiego dei fluorochinoloni nelle infezioni diverse da quelle respiratorie ed urinarie 75
Bacterial infections of the gastrointestinal tract in HIV-infected patients 75
La mononucleosi infezione degli anni verdi 75
Incidence of glycopeptide-resistant enterococci and use of glycopeptides in a Florence hospital 75
Utilizzo dei carbapenemici nella terapia delle infezioni intraddominali 75
In vitro antibacterial activity of imipenem and other agents against Gram-negative and Gram-positive strains isolated from clinical specimens 75
Totale 12.857
Categoria #
all - tutte 41.521
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.521


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.489 0 0 0 0 0 329 176 369 154 118 323 20
2020/20212.422 184 140 259 278 66 366 83 244 132 338 48 284
2021/20221.055 41 168 9 89 21 24 28 73 24 25 269 284
2022/20232.708 318 227 67 250 306 643 255 154 311 38 109 30
2023/2024892 69 139 224 102 52 79 17 153 2 12 28 15
2024/20254.877 221 733 371 926 1.845 781 0 0 0 0 0 0
Totale 18.104